Kiora Pharmaceuticals, Inc. SEC filings and other documents

Explore the latest company documents and SEC filings from Kiora Pharmaceuticals, Inc., including Forms 10-K, 10-Q, 8-K, and other key disclosures. Evaluate financial performance and operational updates to make more informed decisions.

Description

Event date

Documents and forms

2025

Q2 2025

Aug 8, 2025

Earnings release8-K

Quarterly report10-Q

Q1 2025

May 8, 2025

Earnings release8-K

Quarterly report10-Q

2024

Q4 2024

Mar 25, 2025

Earnings release8-K

Annual report10-K

Q3 2024

Nov 8, 2024

Earnings release8-K

Lytham Partners Fall 2024 Investor Conference

Oct 1, 2024

Slides

Q2 2024

Aug 9, 2024

Quarterly report10-Q

Earnings release8-K

Q1 2024

May 10, 2024

Quarterly report10-Q

Earnings release8-K

2023

Q4 2023

Mar 25, 2024

Earnings release8-K

Q3 2023

Nov 9, 2023

Quarterly report10-Q

Earnings release8-K

Study Result

Nov 4, 2023

Press release

Q2 2023

Aug 8, 2023

Quarterly report10-Q

Earnings release8-K

Q1 2023

May 9, 2023

Quarterly report10-Q

Earnings release8-K

2022

Q4 2022

Mar 23, 2023

Earnings release8-K

Q3 2022

Nov 9, 2022

Quarterly report10-Q

Earnings release8-K

Q2 2022

Aug 12, 2022

Quarterly report10-Q

Earnings release8-K

Q1 2022

Jul 8, 2022

Quarterly report10-Q

2021

Q4 2021

Apr 15, 2022

Earnings release8-K

Q3 2021

Nov 15, 2021

Quarterly report10-Q

Earnings release8-K

Q2 2021

Aug 12, 2021

Quarterly report10-Q

Earnings release8-K

Q1 2021

May 12, 2021

Quarterly report10-Q

Earnings release8-K